Cosmo Pharmaceuticals N.V. has announced the launch of Winlevi® (clascoterone) cream 1% in Singapore and Malaysia, marking its entry into Southeast Asia through a partnership with Hyphens Pharma International Limited. This topical treatment for acne vulgaris is aimed at patients aged twelve and older. The collaboration is part of Cosmo's strategy to expand its global reach and address the increasing demand for advanced acne care in the region. This launch is a significant step towards offering innovative dermatology solutions and improving the quality of life for millions affected by acne.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmo Pharmaceuticals NV published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.